Trials / Conditions / Degenerative Osteoarthritis

Degenerative Osteoarthritis

20 registered clinical trials studyying Degenerative Osteoarthritis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis NCT05276011	Kolon TissueGene, Inc.	Phase 2
Withdrawn	Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis NCT05742763	QC Kinetix LLC	Phase 1 / Phase 2
Recruiting	Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty NCT05302934	Aesculap AG	—
Unknown	Continuous Distal Adductor Canal Block With Periarticular Local Anesthetic Infiltration Versus Continuous Dist NCT05427019	Yonsei University	N/A
Completed	Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis NCT06254976	Kayseri City Hospital	N/A
Active Not Recruiting	Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the K NCT03291470	Kolon TissueGene, Inc.	Phase 3
Active Not Recruiting	Plasmafit® Revision Structan® Hip Endoprosthesis Cup NCT04255966	Aesculap AG	—
Completed	AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polye NCT05291130	Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty	—
Completed	Orthopilot Elite Post-Market Clinical Follow-Up NCT03817632	Aesculap AG	—
Unknown	Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty NCT03849885	Colorado Joint Replacement	Phase 4
Active Not Recruiting	A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of NCT03203330	Kolon TissueGene, Inc.	Phase 3
Active Not Recruiting	CoreHip - Post Market Clinical Follow-Up Study NCT03685110	Aesculap AG	—
Completed	Non-Interventional, Multicenter Bicontact® E PMCF Study NCT03442855	Aesculap AG	—
Unknown	UCMSC Transplantation in the Treatment of Cartilage Damage NCT02776943	South China Research Center for Stem Cell and Regenerative Medicine	Phase 1 / Phase 2
Completed	VEGA Prospective Kiel NCT02802085	Aesculap AG	—
Completed	All Polyethylene Tibia-VEGA Kiel NCT02756702	Aesculap AG	—
Unknown	Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (H NCT02687399	Thrombotargets Europe S.L	Phase 2 / Phase 3
Completed	Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Def NCT01626677	Medipost Co Ltd.	Phase 3
Completed	Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone Marrow NCT01335243	University Hospital, Bordeaux	Phase 2
Completed	Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft NCT01413061	AlloSource	N/A